Laakso M - Search Results

1

Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study.

Koivisto AM, Lempiäinen P, Koivisto K, Helkala EL, Mykkänen L, Kuusisto J, Kervinen K, Kesäniemi YA, Laakso M, Soininen H. Koivisto AM, et al. Among authors: laakso m. Neuroepidemiology. 2000 Nov-Dec;19(6):327-32. doi: 10.1159/000026272. Neuroepidemiology. 2000. PMID: 11060507

2

Diabetes mellitus and brain atrophy: a computed tomography study in an elderly population.

Soininen H, Puranen M, Helkala EL, Laakso M, Riekkinen PJ. Soininen H, et al. Among authors: laakso m. Neurobiol Aging. 1992 Nov-Dec;13(6):717-21. doi: 10.1016/0197-4580(92)90095-f. Neurobiol Aging. 1992. PMID: 1491737

3

Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes.

Jäkälä P, Hänninen T, Ryynänen M, Laakso M, Partanen K, Mannermaa A, Soininen H. Jäkälä P, et al. Among authors: laakso m. J Clin Invest. 1997 Jul 15;100(2):331-8. doi: 10.1172/JCI119538. J Clin Invest. 1997. PMID: 9218509 Free PMC article.

4

Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.

Riekkinen P Jr, Riekkinen M, Soininen H, Kuikka J, Laakso M, Riekkinen P Sr. Riekkinen P Jr, et al. Among authors: laakso m. Neuroreport. 1997 May 27;8(8):1845-9. doi: 10.1097/00001756-199705260-00011. Neuroreport. 1997. PMID: 9223063 Clinical Trial.

5

THA disrupts mismatch negativity in Alzheimer disease.

Riekkinen P Jr, Pääkkönen A, Karhu J, Partanen J, Soininen H, Laakso M, Riekkine P Sr. Riekkinen P Jr, et al. Among authors: laakso m. Psychopharmacology (Berl). 1997 Sep;133(2):203-6. doi: 10.1007/s002130050392. Psychopharmacology (Berl). 1997. PMID: 9342788 Clinical Trial.

6

Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.

Kuusisto J, Koivisto K, Mykkänen L, Helkala EL, Vanhanen M, Hänninen T, Kervinen K, Kesäniemi YA, Riekkinen PJ, Laakso M. Kuusisto J, et al. Among authors: laakso m. BMJ. 1997 Oct 25;315(7115):1045-9. doi: 10.1136/bmj.315.7115.1045. BMJ. 1997. PMID: 9366728 Free PMC article.

7

New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland.

Rissanen J, Pihlajamäki J, Heikkinen S, Kekäläinen P, Mykkänen L, Kuusisto J, Kolle A, Laakso M. Rissanen J, et al. Among authors: laakso m. Diabetologia. 1997 Nov;40(11):1313-9. doi: 10.1007/s001250050826. Diabetologia. 1997. PMID: 9389424

8

Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease.

Riekkinen M, Soininen H, Riekkinen P Sr, Kuikka J, Laakso M, Helkala EL, Partanen J, Riekkinen P Jr. Riekkinen M, et al. Among authors: laakso m. Neuroscience. 1998 Mar;83(2):471-9. doi: 10.1016/s0306-4522(97)00400-4. Neuroscience. 1998. PMID: 9460755 Clinical Trial.

9

Cognitive function in an elderly population with persistent impaired glucose tolerance.

Vanhanen M, Koivisto K, Kuusisto J, Mykkänen L, Helkala EL, Hänninen T, Riekkinen P Sr, Soininen H, Laakso M. Vanhanen M, et al. Among authors: laakso m. Diabetes Care. 1998 Mar;21(3):398-402. doi: 10.2337/diacare.21.3.398. Diabetes Care. 1998. PMID: 9540022

10

Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.

Rissanen J, Saarinen L, Heikkinen S, Kekäläinen P, Mykkänen L, Kuusisto J, Deeb SS, Laakso M. Rissanen J, et al. Among authors: laakso m. Diabetes Care. 1998 Jul;21(7):1194-7. doi: 10.2337/diacare.21.7.1194. Diabetes Care. 1998. PMID: 9653619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,392 results

Search Page

Filters